Glenmede Trust’s Organigram Holdings OGI Stock Holding History

Glenmede Trust’s Portfolio OGI Stock Details OGI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-750	Closed	-$3K	–	1908
2020 Q3	$3K	Hold	750	–	–	﹤0.01%	2199
2020 Q2	$4K	Hold	750	–	–	﹤0.01%	2130
2020 Q1	$7K	Hold	750	–	–	﹤0.01%	2571
2019 Q4	$7K	Hold	750	–	–	﹤0.01%	2571
2019 Q3	$10	Hold	750	–	–	﹤0.01%	2354
2019 Q2	$19	Buy	+750	New	+$20.8K	﹤0.01%	2081

Other funds holding OGI

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Glenmede Trust's OGI Position: Q4 2020 in Review

Glenmede Trust sold out of Organigram Holdings (OGI) in Q4 2020, closing a stake of 750 shares — an estimated $3K sold.

Glenmede Trust first reported a position in OGI in Q2 2019 and held it in 6 quarters. The position peaked at $7K in Q1 2020. 106 funds tracked by Wall St. Rank hold OGI as of Q4 2020.

Glenmede Trust reported no remaining Organigram Holdings position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 750 Organigram Holdings shares in Q4 2020, an estimated $3K.
Glenmede Trust first reported a position in Organigram Holdings in Q2 2019 and held it in 6 quarters.
Glenmede Trust's Organigram Holdings position peaked at $7K in Q1 2020.
106 funds tracked by Wall St. Rank held Organigram Holdings as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.